Individual Shareholder Files Provisional Disposition Against Enzychem Lifesciences for Accounting Book Inspection, Raising Governance Concerns
An individual shareholder, identified as Nam, filed a provisional disposition application with the Cheongju District Court Jecheon Branch to inspect and copy the accounting books of Enzychem Lifesciences. The claim is based on Article 466 of the Commercial Act, with a claimed value of 100 million KRW.
The court received the filing on July 7, 2026, and the company stated it will respond through proper legal procedures. This action may signal the beginning of a management dispute, warranting investor attention.
The demand for accounting book inspection indicates escalating shareholder conflict, potentially leading to further litigation or management changes. However, no immediate capital changes or financing plans are involved.
[AI Summary]The provisional disposition request by an individual shareholder highlights governance risks with limited short-term financial impact but increased long-term uncertainty. Investors should monitor subsequent legal developments.
KOSDAQ Filing Information
Filing Of Lawsuit, Etc. (Management Dispute Lawsuit) (Injunction For Inspection And Copying Of Accounting Books)